Basic Information
RNALocate ID: RLID:11001324
RNA Symbol: hsa-miR-148a-3p
Localization: Extracellular vesicle
RNA Information
RNA Name: hsa-miR-148a
RNA ID: miRBase:MIMAT0000243
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 22849433
Tissue/Cell Line: HEK-293T cells
Method: Next-generation RNA sequencing
Description: The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001570 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:11001317 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11001318 Exosome Breast milk 22211110
RLID:11001319 Exosome Brain tissue 23382797
RLID:11001320 Exosome Plasma 23663360
RLID:11001321 Exosome Human mast cell line (HMC-1) 24009880
RLID:11001322 Exosome Human esophageal cancer cell line (EC9706) 25184951
RLID:11001323 Exosome Saliva 25376581
RLID:11001325 Microvesicle Seminal plasma 23539611
RLID:11001326 Microvesicle Hepatoma cells 23771658
RLID-D:11000041 Exosome Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue
RLID-D:11000310 Microvesicle Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-148a-3p Splenic marginal zone lymphoma MNDR-E-MI-15916
MNDR hsa-miR-148a-3p Multiple sclerosis chronic progressive MNDR-E-MI-15917
MNDR hsa-miR-148a-3p Oral squamous cell carcinoma MNDR-E-MI-15918
MNDR hsa-miR-148a-3p Medulloblastoma MNDR-E-MI-15919
MNDR hsa-miR-148a-3p Lymphoma MNDR-E-MI-15920
MNDR hsa-miR-148a-3p Lymphoma non-hodgkin MNDR-E-MI-15921
MNDR hsa-miR-148a-3p Estrogen-receptor positive breast cancer MNDR-E-MI-15922
MNDR hsa-miR-148a-3p Progesterone-receptor positive breast cancer MNDR-E-MI-15923
MNDR hsa-miR-148a-3p Progesterone-receptor negative breast cancer MNDR-E-MI-15924
MNDR hsa-miR-148a-3p Breast cancer luminal MNDR-E-MI-15925
MNDR hsa-miR-148a-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-15926
MNDR hsa-miR-148a-3p Autosomal recessive limb-girdle muscular dystrophy type 2a MNDR-E-MI-15927
MNDR hsa-miR-148a-3p Dermatomyositis MNDR-E-MI-15928
MNDR hsa-miR-148a-3p Castration-resistant prostate cancer MNDR-E-MI-15929
MNDR hsa-miR-148a-3p Gastric cancer MNDR-E-MI-15930
MNDR hsa-miR-148a-3p Alzheimer disease MNDR-E-MI-15931
MNDR hsa-miR-148a-3p Intracranial aneurysm MNDR-E-MI-15932
MNDR hsa-miR-148a-3p Bladder cancer MNDR-E-MI-15933
MNDR hsa-miR-148a-3p Esophageal carcinoma MNDR-E-MI-15934
MNDR hsa-miR-148a-3p Dysautonomia familial MNDR-E-MI-15935
MNDR hsa-miR-148a-3p Myotonic dystrophy MNDR-E-MI-15936
MNDR hsa-miR-148a-3p Muscular dystrophy duchenne MNDR-E-MI-15937
MNDR hsa-miR-148a-3p Leukemia MNDR-E-MI-15938
MNDR hsa-miR-148a-3p Huntington disease MNDR-E-MI-15939
MNDR hsa-miR-148a-3p Chorea MNDR-E-MI-15940
MNDR hsa-miR-148a-3p Cardiovascular disease MNDR-E-MI-15941
MNDR hsa-miR-148a-3p Parkinson disease MNDR-E-MI-15942
MNDR hsa-miR-148a-3p Breast cancer MNDR-E-MI-15943
MNDR hsa-miR-148a-3p Neuroendocrine neoplasia MNDR-E-MI-15944
MNDR hsa-miR-148a-3p Pituitary neoplasms MNDR-E-MI-15945
MNDR hsa-miR-148a-3p Pancreatic cancer MNDR-E-MI-15946
MNDR hsa-miR-148a-3p Intrahepatic cholestasis MNDR-E-MI-15947
MNDR hsa-miR-148a-3p Melanoma MNDR-E-MI-15948
MNDR hsa-miR-148a-3p Rectum adenocarcinoma MNDR-E-MI-15949
MNDR hsa-miR-148a-3p Nephroblastoma MNDR-E-MI-15950
MNDR hsa-miR-148a-3p Colon cancer MNDR-E-MI-15951
MNDR hsa-miR-148a-3p Ischemic attack transient MNDR-E-MI-15952
MNDR hsa-miR-148a-3p Colon adenocarcinoma MNDR-E-MI-15953
MNDR hsa-miR-148a-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-15954
MNDR hsa-miR-148a-3p Familial ovarian cancer MNDR-E-MI-15955
MNDR hsa-miR-148a-3p Prostate adenocarcinoma MNDR-E-MI-15956
MNDR hsa-miR-148a-3p Hematologic cancer MNDR-E-MI-15957
MNDR hsa-miR-148a-3p Carcinoma ductal breast MNDR-E-MI-15958
MNDR hsa-miR-148a-3p Glioblastoma MNDR-E-MI-15959
MNDR hsa-miR-148a-3p Glioma MNDR-E-MI-15960
MNDR hsa-miR-148a-3p Nemaline myopathy MNDR-E-MI-15961
MNDR hsa-miR-148a-3p Central nervous system lymphoma MNDR-E-MI-15962
MNDR hsa-miR-148a-3p Amyotrophic lateral sclerosis MNDR-E-MI-15963
MNDR hsa-miR-148a-3p Pancreatic ductal adenocarcinoma MNDR-E-MI-15964
MNDR hsa-miR-148a-3p Uterine cancer MNDR-E-MI-15965
MNDR hsa-miR-148a-3p Cervical squamous cell carcinoma MNDR-E-MI-15966
MNDR hsa-miR-148a-3p Pituitary adenoma MNDR-E-MI-15967
MNDR hsa-miR-148a-3p Lung squamous cell carcinoma MNDR-E-MI-15968
MNDR hsa-miR-148a-3p Lung adenocarcinoma MNDR-E-MI-15969
MNDR hsa-miR-148a-3p Acute myocarditis MNDR-E-MI-15970
MNDR hsa-miR-148a-3p Thyroid carcinoma MNDR-E-MI-15971
MNDR hsa-miR-148a-3p Bladder urothelial carcinoma MNDR-E-MI-15972
MNDR hsa-miR-148a-3p Pancreatic adenocarcinoma MNDR-E-MI-15973
MNDR hsa-miR-148a-3p Skin cancer MNDR-E-MI-15974
MNDR hsa-miR-148a-3p Kidney renal clear cell carcinoma MNDR-E-MI-15975
MNDR hsa-miR-148a-3p Kidney renal papillary cell carcinoma MNDR-E-MI-15976
MNDR hsa-miR-148a-3p Renal clear cell carcinoma MNDR-E-MI-15977
MNDR hsa-miR-148a-3p Intrahepatic cholangiocarcinoma MNDR-E-MI-15978
MNDR hsa-miR-148a-3p Cholangiocarcinoma MNDR-E-MI-15979
MNDR hsa-miR-148a-3p Esophageal cancer MNDR-E-MI-15980
MNDR hsa-miR-148a-3p Liver cirrhosis MNDR-E-MI-15981
MNDR hsa-miR-148a-3p Lung small cell carcinoma MNDR-E-MI-15982
MNDR hsa-miR-148a-3p Head and neck squamous cell carcinoma MNDR-E-MI-15983
MNDR hsa-miR-148a-3p Aortic valve disease MNDR-E-MI-15984
MNDR hsa-miR-148a-3p Breast invasive carcinoma MNDR-E-MI-15985
MNDR hsa-miR-148a-3p Early hepatocellular carcinoma MNDR-E-MI-15986
MNDR hsa-miR-148a-3p Familiar ovarian carcinoma MNDR-E-MI-15987
MNDR hsa-miR-148a-3p B-cell lymphoma MNDR-E-MI-15988
MNDR hsa-miR-148a-3p Rheumatoid arthritis MNDR-E-MI-15989
MNDR hsa-miR-148a-3p T-cell leukemia MNDR-E-MI-15990
MNDR hsa-miR-148a-3p Malignant pleural mesothelioma MNDR-E-MI-15991
MNDR hsa-miR-148a-3p Hodgkin lymphoma MNDR-E-MI-15992
MNDR hsa-miR-148a-3p Burkitt lymphoma MNDR-E-MI-15993
MNDR hsa-miR-148a-3p Neuromyelitis optica MNDR-E-MI-15994
MNDR hsa-miR-148a-3p Skin cutaneous melanoma MNDR-E-MI-15995
MNDR hsa-miR-148a-3p Skin melanoma MNDR-E-MI-15996
MNDR hsa-miR-148a-3p Acute myelocytic leukemia MNDR-E-MI-15997
MNDR hsa-miR-148a-3p Colorectal cancer MNDR-E-MI-15998
MNDR hsa-miR-148a-3p Multiple myeloma MNDR-E-MI-15999
MNDR hsa-miR-148a-3p Acute lymphocytic leukemia MNDR-E-MI-16000
MNDR hsa-miR-148a-3p Ependymoma MNDR-E-MI-16001
MNDR hsa-miR-148a-3p Nasopharyngeal cancer MNDR-E-MI-16002
MNDR hsa-miR-148a-3p Epstein-barr virus infections MNDR-E-MI-16003
MNDR hsa-miR-148a-3p Stroke lacunar MNDR-E-MI-16004
MNDR hsa-miR-148a-3p Low grade dysplastic nodule MNDR-E-MI-16005
MNDR hsa-miR-148a-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-16006
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ACVR1 Homo sapiens RR00038737
TOP